研究者総覧 - 戸髙　明子

トダカ　アキコ
戸髙　明子

所属大分大学医学部附属病院中診特診・輸血部

職種講師

論文
論文	Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113. International journal of clinical oncology 30 (10),2053-2062頁 2025/10
論文	Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1 treatment: A propensity score-matched analysis Pancreatology 2025/09
論文	Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, non-comparative trial. Gastrointestinal endoscopy 2025/06/28
論文	Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113. Japanese journal of clinical oncology 55 (6),594-602頁 2025/06/05
論文	Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: A supplementary analysis of JCOG1407. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2025/02/10
論文	Cytokine release syndrome treated with tocilizumab following ipilimumab-nivolumab combination therapy in advanced renal cell carcinoma. IJU case reports 8 (1),64-68頁 2025/01
論文	Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113. International journal of clinical oncology 2024/10/23
論文	5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1). Journal of hepato-biliary-pancreatic sciences 2024/09/25
論文	A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (18),3990-3995頁 2024/09/13
論文	Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia. BMC palliative care 23 (1),214-214頁 2024/08/24
論文	The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial cancer 23 (3),393-398頁 2024/08
論文	Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Hereditary cancer in clinical practice 22 (1),11-11頁 2024/07/03
論文	膵癌におけるPrecision medicineの現状と将来展望 MSI-H肝胆膵癌に対するペムブロリズマブの治療成績膵臓 39 (3),A283-A283頁 2024/07
論文	Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study. The oncologist 28 (11),e1108-e1113 2023/11/02
論文	A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT). Annals of surgical oncology 30 (12),7331-7337頁 2023/11
論文	ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials. Annals of surgical oncology 30 (12),7384-7385頁 2023/11
論文	Correction: A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT). Annals of surgical oncology 30 (11),6651-6651頁 2023/10
論文	Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumab. Clinical journal of gastroenterology 16 (5),748-754頁 2023/10
論文	FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis. Anticancer research 43 (9),4115-4123頁 2023/09
論文	Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113 The Oncologist 29 (1),e97-e107頁 2023/08/02
論文	免疫チェックポイント阻害剤を用いた膵癌治療:基礎から臨床まで MSI-High膵癌の臨床的特徴とペムブロリズマブの治療効果膵臓 38 (3),A211-A211頁 2023/07
論文	Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment. Japanese journal of clinical oncology 2023/06/15
論文	Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors. Cancer chemotherapy and pharmacology 91 (6),469-480頁 2023/06
論文	Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106. Japanese journal of clinical oncology 53 (8),704-713頁 2023/05/29
論文	Long-term adjuvant chemotherapy after resection for pancreatic cancer patients with positive peritoneal lavage cytology. Langenbeck's archives of surgery 408 (1),165-165頁 2023/04/27
論文	実臨床における化学療法+Nivolumab併用療法の有効性と安全性に関する検討日本消化器病学会雑誌 120 (臨増総会),A313-A313頁 2023/03
論文	Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. Journal of human genetics 68 (2),81-86頁 2023/02
論文	胃切除されたCY1症例の治療方針 CY1胃癌に対する術後化学療法の有効性と安全性日本胃癌学会総会記事 95回,202-202頁 2023/02
論文	Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet (London, England) 401 (10372),195-203頁 2023/01/21
論文	Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. BMC cancer 23 (1),68-68頁 2023/01/20
論文	A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407). European journal of cancer (Oxford, England : 1990) 181,135-144頁 2022/12/27
論文	Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study. Investigational new drugs 40 (5),1106-1116頁 2022/10
論文	Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 22 (8),1159-1166頁 2022/09/08
論文	Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer. The oncologist 27 (10),e774-e782 2022/08/10
論文	ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence. Annals of surgical oncology 29 (8),5003-5004頁 2022/08
論文	The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. Annals of surgical oncology 29 (8),4992-5002頁 2022/08
論文	The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy. Journal of hepato-biliary-pancreatic sciences 29 (8),922-931頁 2022/08
論文	Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study. Anticancer research 42 (2),893-902頁 2022/02
論文	Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report. Surgical case reports 8 (1),20-20頁 2022/01/26
論文	The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113. Scientific reports 12 (1),987-987頁 2022/01/19
論文	Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses. BMC cancer 22 (1),73-73頁 2022/01/17
論文	Predictive factors of survival in patients with borderline resectable pancreatic cancer who received neoadjuvant therapy Pancreatology 21 (8),1451-1459頁 2021/12/01
論文	Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113. Scientific reports 11 (1),12885-12885頁 2021/06/18
論文	Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer. Investigational new drugs 39 (5),1399-1404頁 2021/04/09
論文	Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106. Japanese journal of clinical oncology 51 (2),235-243頁 2021/02/08
論文	Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing Regimens. Pancreas 50 (1),77-82頁 2021/01/01
論文	FOLFIRINOX for Recurrent Pancreatic Cancer After Pancreatic Resection Pancreas 49 (10),1372-1377頁 2020/11
論文	Prognostic impact of abutment to the branches of the superior mesenteric artery in borderline resectable pancreatic cancer. Langenbeck's archives of surgery 405 (7),939-947頁 2020/11
論文	FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20 (7),1519-1525頁 2020/10
論文	Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma. Annals of gastroenterological surgery 4 (4),455-463頁 2020/07
論文	Prognostic role of the length of tumour–vein contact at the portal–superior mesenteric vein in patients having surgery for pancreatic cancer BJS 106 (12),1649-1656頁 2019/11
論文	Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy. Japanese journal of clinical oncology 49 (10),910-918頁 2019/10/01
論文	Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer. Oncotarget 10 (19),1775-1784頁 2019/03/05
論文	FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 19 (2),296-301頁 2019/03
論文	Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX. Cancer science 110 (2),707-716頁 2019/02
論文	Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer. International journal of clinical oncology 23 (6),1084-1089頁 2018/12
論文	Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. International journal of clinical oncology 23 (6),1189-1195頁 2018/12
論文	Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study. BMC cancer 18 (1),993-993頁 2018/10/19
論文	Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value. World journal of surgery 42 (10),3331-3340頁 2018/10
論文	Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study. BMC cancer 18 (1),573-573頁 2018/05/18
論文	Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan Pancreas 47 (5),631-636頁 2018/05
論文	Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 21 (2),338-344頁 2018/03
論文	Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine. Cancer science 109 (1),215-224頁 2018/01
論文	Risk Analysis of Pneumonitis in Taxane Therapy After Chemoradiotherapy for Patients With Metastatic or Recurrent Esophageal Cancer. American journal of clinical oncology 41 (1),41-45頁 2018/01
論文	Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer PANCREATOLOGY 17 (6),983-989頁 2017/11
論文	進行膵癌に対するFOLFIRINOX療法の初期Dose intensityが治療効果に与える影響日本癌治療学会学術集会抄録集 55回,IS5-3頁 2017/10
論文	Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison. Clinical colorectal cancer 16 (2),e15-e22 2017/06
論文	Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102. Clinical colorectal cancer 16 (1),51-57頁 2017/03
論文	A case of multicentric pancreatic mixed acinar-ductal carcinoma diagnosed by a yogurt-like cell clump flowing from the papilla of Vater. BMC gastroenterology 17 (1),20-20頁 2017/01/23
論文	Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study. BMC cancer 17 (1),59-59頁 2017/01/17
論文	Metabolic profiling of gemcitabine- and paclitaxel-treated immortalized human pancreatic cell lines with K-RASG12D. Biomedical research (Tokyo, Japan) 38 (1),29-40頁 2017
論文	Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer. Oncology 93 (5),329-335頁 2017
論文	Current status of FOLFIRINOX in Japan: modified or original? Annals of Oncology 27,vii24-vii24頁 2016/11
論文	Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer. Cancer chemotherapy and pharmacology 78 (4),809-14頁 2016/10
論文	膵臓進行膵がんに対する治療戦略治癒切除不能膵癌に対するFOLFIRINOX療法の大規模観察研究(JASPAC-06) 最終解析結果日本癌治療学会学術集会抄録集 54回,MS14-2頁 2016/10
論文	Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 19 (3),894-901頁 2016/07
論文	Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer. Oncology 91 (2),78-84頁 2016
論文	The Disappearance of Lymph Node Metastasis from Neuroendocrine Carcinoma after Endoscopic Ultrasound-guided Fine Needle Aspiration INTERNAL MEDICINE 55 (19),2805-2809頁 2016
論文	Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin. Molecular and clinical oncology 3 (5),1029-1034頁 2015/09
論文	Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases. International journal of clinical oncology 20 (3),455-62頁 2015/06
論文	[Anaplastic carcinoma of the pancreas]. Nihon rinsho. Japanese journal of clinical medicine 73 Suppl 3,194-8頁 2015/03
論文	Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancer. International journal of clinical oncology 19 (6),1037-42頁 2014/12
論文	Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa. Japanese journal of clinical oncology 44 (9),792-8頁 2014/09
論文	【膵がん退治の始まり】術後補助化学療法の新展開肝胆膵 68 (6),895-900頁 2014/06
論文	Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy. International journal of clinical oncology 18 (5),864-8頁 2013/10
論文	Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer. International journal of clinical oncology 18 (1),10-6頁 2013/02
論文	Leptomeningeal carcinomatosis associated with gastric cancer. International journal of clinical oncology 17 (4),361-6頁 2012/08
論文	Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study. Japanese journal of clinical oncology 42 (8),686-90頁 2012/08
論文	S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy. Japanese journal of clinical oncology 41 (12),1351-7頁 2011/12
論文	Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta. International journal of clinical oncology 16 (4),359-65頁 2011/08
論文	Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis. International journal of clinical oncology 15 (3),287-93頁 2010/06
論文	S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure. Japanese journal of clinical oncology 40 (6),567-72頁 2010/06
論文	Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 12 (4),206-11頁 2009
論文	[Palliative care team support services by the hospital for home palliation]. Gan to kagaku ryoho. Cancer & chemotherapy 33 Suppl 2,349-51頁 2006/12
論文	[The role of an oncology certified nurse specialist in a palliative care team]. Gan to kagaku ryoho. Cancer & chemotherapy 33 Suppl 2,345-7頁 2006/12